S. 4698 is a bill that aims to modify the Federal Food, Drug, and Cosmetic Act to allow patients who are diagnosed with life-threatening diseases or severely debilitating illnesses to access investigational individualized medical treatments. This means that patients could potentially use experimental treatments that have not yet been fully approved by the FDA, giving them more options in desperate situations.
Supporters of S. 4698 have praised the bill for providing hope and increased treatment options for patients facing dire health situations. They argue that it empowers patients and doctors to make informed choices about experimental therapies that could potentially save lives.
Critics of S. 4698 have expressed concerns about the safety and efficacy of allowing access to unapproved treatments. They worry that this could lead to patients using ineffective or harmful therapies, and that it may undermine the rigorous FDA approval process designed to ensure public safety.
The analysis of bill S. 4698, which aims to amend the Federal Food, Drug, and Cosmetic Act to allow investigational individualized medical treatments for patients with life-threatening diseases, reveals no direct industry overlaps between the sponsor Ron Johnson's top donor industries and the subject matter of the bill. The lobbying activity in this area includes significant contributions from industries such as SASOL CHEMICALS USA LLC, which contributed $260,000, but this does not directly relate to the medical treatment focus of the bill. The absence of direct financial ties suggests a low risk of conflicts of interest. Voters should be aware that while lobbying exists, the lack of direct industry overlap mitigates potential concerns regarding undue influence on the bill's intent.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| SASOL CHEMICALS USA LLC | SASOL CHEMICALS USA LLC | $260,000 |
| ENERGY INFRASTRUCTURE COUNCIL FKA MASTER LIMITED PARTNERSHIP ASSOCIATION | ZIEBART CONSULTING, LLC | $60,000 |
| ORGANIC PRODUCE ASSOCIATION | THE RUSSELL GROUP, INC. | $50,000 |
| GRAVITICS | TECHNOLOGY STRATEGIES LLC | $30,000 |
| LIVINGSTON INTERNATIONAL INC | VENABLE LLP | $30,000 |
| CITY OF WILLISTON (ND) | NEXXUS CONSULTING, LLC | $30,000 |
| NATIONAL ASSOCIATION OF POSTAL SUPERVISORS | NATIONAL ASSOCIATION OF POSTAL SUPERVISORS | $28,000 |
| S&P GLOBAL F/K/A IHS MARITIME & TRADE | VENABLE LLP | $20,000 |
| TOWN OF TUSAYAN | NEXXUS CONSULTING, LLC | $10,000 |
| TREA SENIOR CITIZENS LEAGUE | TREA SENIOR CITIZENS LEAGUE | $5,000 |
| NATIONAL RELIGIOUS BROADCASTERS | NATIONAL RELIGIOUS BROADCASTERS | undisclosed |
| INTERNATIONAL REGISTRIES, INC. | VENABLE LLP | undisclosed |
| ARISTEIA STRATEGIC ADVISORS, LLC | ARISTEIA STRATEGIC ADVISORS, LLC | undisclosed |
| US CHEMICAL TECHNOLOGIES | ATS COMMUNICATIONS, INC. (DBA SILBEY STRATEGIES) | undisclosed |
| CX2 | ATS COMMUNICATIONS, INC. (DBA SILBEY STRATEGIES) | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Ron Johnson, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
